Skip to content

Assessment of the effect of thrombophilia genes on anticoagulant efficacy and bleeding risk after total knee replacement: A multicenter retrospective cohort study

Assessment of the effect of thrombophilia genes on anticoagulant efficacy and bleeding risk after total knee replacement: A multicenter retrospective cohort study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600120538
Enrollment
Unknown
Registered
2026-03-16
Start date
2026-03-22
Completion date
Unknown
Last updated
2026-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Deep vein thrombosis after total knee arthroplasty

Interventions

Grouped into CC the sequencing results of SERPINC1 gene:None
Grouped into CT group according the sequencing results of SERPINC1 gene:None
Grouped into CT group the sequencing results of SERPINC1 gene:None

Sponsors

Shanghai Tenth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Aged between 18 and 80 years old; 2.Elective TKA surgery; 3.Undergo high-risk genetic testing for venous thromboembolism, including at least the detection of the SERPINC1 genotype. 4.Standard use of anticoagulant drugs after surgery;

Exclusion criteria

Exclusion criteria: 1. History of deep vein thrombosis (DVT) or pulmonary thromboembolism (PTE); 2.Blood transfusion during or after surgery; 3.Blood disorders; 4.Surgical procedures in the past 3 months; 5.Menstrual periods or pregnancy; 6.History of malignancy.

Design outcomes

Primary

MeasureTime frame
DD dimer level;

Secondary

MeasureTime frame
lower limb venous ultrasound or venography results;Hemoglobin levels;Platelet;APTT value;

Countries

China

Contacts

Public ContactRan Wu

Shanghai Tenth People's Hospital

2277244342@qq.com+86 21 6630 2570

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 3, 2026